Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-08-13
1999-06-15
Cook, Rebecca
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514825, 514826, 514866, 514903, A61K 3135
Patent
active
059122668
ABSTRACT:
This invention concerns compositions and methods utilizing a compound of the formula: ##STR1## for reducing or controlling inflammation and treating pathological conditions mediated by intercellular adhesion. More particularly, the present invention concerns compositions and methods for blocking or modulating the function of the Beta.sub.2 Integrin family of cell adhesion molecules.
REFERENCES:
patent: 3909362 (1975-09-01), Jiu et al.
patent: 5232917 (1993-08-01), Bolger et al.
Marlin et al., Cell, vol. 51, pp. 813-819, 1987.
Rothlein et al J. of Immunology, vol. 137, pp. 1270-1274, 1986.
Makgoba et al Nature, vol. 331, pp. 86-88, 1988.
Dustin et al., J. of Immunology, vol. 137, pp. 245-255, 1986.
Mizuba et al. Can. J. Microbiol., vol. 21, pp. 1781-1787, 1975.
Argoudelis et al., Tetrahedron Letters, vol. 18, pp. 1969-1973, 1966.
Owen et al., Antimicrobial Agents and Chemotherapy, vol. 1965, pp. 804-807, 1966.
Ramesh et al., Tetrahedron: Asymmetry, vol. 1, pp. 137-140, 1990.
Staunton et al., Cell, vol. 52, pp. 925-933, 1988.
American Home Products Corporation
Cook Rebecca
Eck Steven R.
LandOfFree
Beta.sub.2 integrin cell adhesion molecule inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Beta.sub.2 integrin cell adhesion molecule inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Beta.sub.2 integrin cell adhesion molecule inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-402850